75D30122F15322↗
Lantana Consulting Group, Inc received this contract from CDC Office of Acquisition Services, Centers for Disease Control and Prevention: $67.58M obligated so far for support- professional: other. It runs to 2027-09-30.
Key facts · data as of Oct 21, 2026
- Recipient
- Lantana Consulting Group, Inc
- Awarding agency
- Centers for Disease Control and Prevention (Department of Health and Human Services)
- Contracting office
- CDC Office of Acquisition Services (75D301)
- Obligated to date
- $67.58M
- Potential value
- $81.46M
- Ends
- 2027-09-30
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 21, 2026.
Cite this page: SpendQuery, Award 75D30122F15322, data as of Oct 21, 2026, https://spendquery.com/award?id=CONT_AWD_75D30122F15322_7523_47QTCA21D001V_4732
Lantana Consulting Group, Inc: all federal awards · Department of Health and Human Services: spending · CDC Office of Acquisition Services: what it buys · The follow-on: recompete brief
ANALYTIC SUPPORT FOR ADVERSE DRUG EVENT SURVEILLANCE AND STATISTICAL ANALYSIS
Up for re-bid: ends 2027-09-30. Recompete brief → · Dose Reconstruction and Related Activities to Support NIOSH's Responsibilities under the Energy Employees Occupational Illness Compensation Act (EEOICPA) ↗
What it is
- Product or service
- Support- Professional: Other (PSC R499)
- Industry
- Other Computer Related Services (NAICS 541519)
- Contracting office
- CDC Office of Acquisition Services (75D301)
- Competition
- Full and open competition · 1 offer received
- Pricing
- Firm fixed price
- How it was bought
- GSA Schedule · under 47QTCA21D001V
- Solicitation
- 75D301-22-Q-75275
- Where the work is
- Orange, VT · district VT-00
- Funding law
- COVID-19 laws
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
8 actions since 2023-05-02. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-06-09 | P00008 | Administrative change | $0 | EO 14398 |
| 2026-05-27 | P00007 | Administrative change | $0 | ANALYTIC SUPPORT FOR ADVERSE DRUG EVENT SURVEILLANCE AND STATISTICAL ANALYSIS |
| 2025-03-03 | P00006 | Administrative change | $0 | ANALYTIC SUPPORT FOR ADVERSE DRUG EVENT SURVEILLANCE AND STATISTICAL ANALYSIS |
| 2024-11-08 | P00005 | Administrative change | $0 | ANALYTIC SUPPORT FOR ADVERSE DRUG EVENT SURVEILLANCE AND STATISTICAL ANALYSIS |
| 2024-03-13 | P00004 | Administrative change | $0 | ANALYTIC SUPPORT FOR ADVERSE DRUG EVENT SURVEILLANCE AND STATISTICAL ANALYSIS |
| 2023-12-22 | P00003 | Option exercised | $52.29M | ANALYTIC SUPPORT FOR ADVERSE DRUG EVENT SURVEILLANCE AND STATISTICAL ANALYSIS |
| 2023-08-28 | P00002 | Option exercised | $15.29M | ANALYTIC SUPPORT FOR ADVERSE DRUG EVENT SURVEILLANCE AND STATISTICAL ANALYSIS |
| 2023-05-02 | P00001 | Administrative change | $0 | ANALYTIC SUPPORT FOR ADVERSE DRUG EVENT SURVEILLANCE AND STATISTICAL ANALYSIS |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-21). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗